Member Info for 28jaczar01

@chaebol…..

At todays webinar Argo clarified in the presentation slide that the 2nd NYDIG loan done recently was set at 12% interest per annum, so I hold my hands up to getting that aspect incorrect previously from reading the ambiguously worded loan related RNS. Furthermore, in the Q&A section today they clarified as to why it was set at a higher rate compared to the 1st NYDIG loan.

Glad you didn’t ultimately take me up on my suggestion of the related bet on this matter, and hence I will continue to post here from time to time when it is warranted.

Have a good day.

The trading volumes so far today seem very low across the board for practically all the small cap stocks, even most of those who have published positive RNS (e.g. CRCL, TRAC, etc)…..strange……even wondering if some trading platforms have been down ?

Trust

Yes indeed…….maybe it’s a hint towards the next DVRG revenue stream, Skincare Club identifies the secret of eternal youth ;-)

Interesting article:

Will swapping out electric car batteries catch on? https://www.bbc.co.uk/news/business-61310513

Interesting article:

Will swapping out electric car batteries catch on? https://www.bbc.co.uk/news/business-61310513

Interesting article:

Will swapping out electric car batteries catch on? https://www.bbc.co.uk/news/business-61310513

@spottydog……calling EEE a “dog”. Guess that’s the limit of your name calling vocabulary.

Notable silence from you in the past 3+ months since February, in a period when plenty of positive news was being released by EEE such as as for high grade gold intercepts achieved at Gindalbie and acquiring three new Australia based large acreage prospective copper/gold tenements.

The recent placing was explained in related RNS and it seems to make common sense if you reasonably believe we are entering a commodities bull market that you act to ensure you have sufficient funds in place to timely progress all your multiple assets in parallel without facing penny pinching delay causing constraints.

As for todays drill results, which you attempt to de-ramp……..as is explained in the RNS they are serving well for their primary purpose of providing the required geological & structural information for Eclipse, which has always been the stated intention of this particular drilling phase. There are already plenty of high grade / intercepts established in earlier drilling phases undertaken at Eclipse.

Going forwards in the near term, we can expect EEE to progress very quickly with a follow-up drill program at Gindalbie considering that they have an initial 6 month exploration term in place as announced on 24th Feb and hence have only around 3 months duration remaining to obtain the sufficient information needed for this asset to decide on the path forward.

Hence plenty of upcoming news to look forward to here.

Hoping for VDTK to get a nice piece of the solar pie……we need news.

https://www.pv-magazine.com/2022/05/16/global-solar-demand-to-reach-190-gw-this-year-says-iea/

Genscript Biotech Corporation….Main listing is on the Hong Kong stock market with secondary listings in Europe (Frankfurt, etc) and the USA (OTC market with ticker GNNSF, link below).

https://finance.yahoo.com/quote/GNNSF/

Currently has a market cap of circa 42 billion Hong Kong Dollar which equates to circa 5.3 billion USD……..not too shabby as an upcoming equity partner !!

Wouldn’t put it past AP to have deliberately chosen Friday 13th for this news release, such is his track record……shambles.

Wouldn’t

I guess it should read 16th May 2022…..this coming Monday.

“My word is my bond” is not the case for Atlas unfortunately. They couldn’t resist with the SP rise seen in the past week or so. Gonna be SP re-trace unfortunately as they continue to sell.

Not cross-ramping…..

Noticed the news over at ARCM today. Our NED appointed last year (Nick Von Schirnding) who is their Exec Chairman looks to have pretty much done a copy & paste of the OMI JV agreement for Colombia as the basis for the deal they have reached with Anglo American in Zambia for copper asset (this aspect even gets a mention in their investor webinar held earlier today) .

I think it speaks volumes for the quality of the OMI JV Colombia deal set-up that it’s subsequently been successfully used as the template for another major deal involving a junior explorer and a mining tier 1 major.

https://www.lse.co.uk/rns/ARCM/agreement-with-anglo-american-investor-webinar-oq42ka6ty20vcyh.html

Good news IMO. Peter’s involvement with CBX was unwelcome distraction from his ARB focus.

https://www.lse.co.uk/rns/CBX/board-changes-vnm8hvmwijzeay3.html

Lots of great medical potential I can see here, but the key concern from investment perspective has to be the “sufficient capital into Q4 2022” situation. It is somewhat vague wording that they use, but it could mean as soon as October which is only around 4.5 months away.

Wise management simply wont wait until they are running on fumes with existing funds in order to financially secure the medium term future of the Company, particularly in the rapidly depreciating market conditions environment that the world is currently facing (obtaining new funds will be getting harder and more expensive).

I can therefore envisage some type of financing arrangement (loan/placing/other) is now being actively developed by the recently appointed CFO and team, with a view to put it in place within the next few months by the time we reach the summer holiday period in Q3.

What if Newcrest ultimately walk away from taking the 5% and GGP retains 30% ownership……what would this outcome do for such aspects as :-:

- near term SP.
- financing from GGP for their share of Havieron development.
- GGP / Newcrest relations.
- long term revenue/profit differentials.
- other pertinent aspects.

Appreciate thoughts from knowledgable posters.

Tingo news….sounds positive for their liquidity etc to be incorporated into a Nasdaq stock.

https://seekingalpha.com/news/3835938-mict-jumps-16-with-merger-announcement-with-tingo-estimted-group-value-409b

On 1 trade for 500 quid…..likely best to ignore the SP info here until there is some real liquidity. However I do wonder for how much longer Companies will be able to pull the Covid card as an excuse for delaying the publication of their financial results.

Chaebol……..I am sure enough to make the bet……your the one that first started this post declaring it was 12% per annum….you seem to be back tracking on your viewpoint now to at least be sitting on the fence. I take your no bet reply as weakness and you don’t want to say bye bye yet to all your “friends”on this board. LOL.

Lets summarise:-

- NYDIG previous smaller loan: 8.25% per annum
- chaebol new larger loan viewpoint: 12% per annum (increase of 4% from previous loan)
- 28jaczar01 new larger loan viewpoint: 12% full term (decrease of circa 2% from previous loan)

Larger loan amount in a softening debt market…….hmmmmm…..which viewpoint would our audience choose I wonder….